Search the Community
Showing results for tags 'reliably'.
Found 2 results
Gryphon Myers posted an article in Conferences, Publicity, Pregnancy, Church, Bread Machines, Distillation & BeerCeliac.com 03/18/2013 - People are wary (for good reason) of products that are derived from gluten-containing ingredients, and few products have received quite as much heat as beer. Gluten-removed beers are almost always tested to under 20ppm gluten to allay the concerns of celiacs, but the reliability of such tests is often challenged. Can we really trust the results of gluten tests performed on beer? As Tricia Thompson, MS, RD writes on her blog, Gluten-Free Dietitian, the current standard for testing gluten content in foods is a sandwich ELISA test. The R5 and omega-gliadin versions of the test are the most widely used, and both have been validated in collaborative trials. While sandwich ELISA tests are reliable for detecting gluten in heated and non-heated food items, they are notoriously unreliable for detecting hydrolyzed gluten. Many see this as reason not to trust gluten-removed beers: the fermentation process hydrolyzes gluten in beer, so sandwich ELISA tests cannot accurately quantify their gluten content. If the test is unreliable, it's hard to believe that a once gluten-containing substance is safe for consumption by celiacs. However, the sandwich R5 ELISA's weaknesses are well documented and widely known. Most of these brewers are using an entirely different test that was specifically designed to detect partial gluten fragments (peptides) that may still be harmful to the gluten-sensitive. The competitive R5 ELISA is the standard test used to detect these peptides, and although it has not been validated yet, many published studies have found the competitive R5 ELISA to be a reliable indicator of hydrolyzed gluten. A recent article published on Medical Daily titled “Gluten-Free Beer? Common Gluten Detection Method is Inaccurate” addresses the issue of ELISA testing on beer, and claims that current testing procedures are inaccurate. This is only half true, and unfortunately, articles like these only serve to confuse the public about an already confusing issue. The article seems well-meaning enough; after all, there's nothing wrong with taking a precautionary stance when one's health is on the line. However, the cited study clearly states that they are using the sandwich R5 ELISA. It has already been established that the sandwich R5 ELISA is unreliable for testing beer, and for this reason, most companies do not use it when testing for hydrolyzed gluten. This makes the article's title highly misleading, as the inaccuracy of the sandwich R5 ELISA for detecting gluten in beer is, in most cases, irrelevant. Another point that the article fails to address is that it is not entirely clear just how toxic these gluten peptides are for gluten-sensitive individuals. The toxicity of the 33 mer peptide and numerous others have been demonstrated, but aside from that, it's possible that at least some of the peptides detected by the Competitive R5 ELISA are not toxic to celiacs. One should always err on the side of safety, but it is important to be as precise as possible with the scientific terminology to avoid needless (perhaps inadvertent) fear mongering, as that is one thing the celiac community does not need more of. Parts of this article appeared in “Common Misunderstandings of Gluten-Free Alcoholic Beverages,” from the Winter 2012 issue of The Journal of Gluten Sensitivity. Sources: http://www.glutenfreedietitian.com/newsletter/2012/08/06/standards-for-testing-food-for-gluten-issues-that-need-addressing/ http://www.glutenfreedietitian.com/newsletter/2012/07/24/beer-why-it-is-so-hard-to-assess-fermented-and-hydrolyzed-products-for-gluten/ http://www.ncbi.nlm.nih.gov/pubmed/19763549 http://www.ncbi.nlm.nih.gov/pubmed/22649922 http://www.medicaldaily.com/articles/14181/20130301/gluten-free-beer-common-detection-method-inaccurate.htm
Scott Adams posted an article in Celiac Disease Diagnosis, Testing & TreatmentV. Kumar,* M. Jarzabek-Chorzelska, J. Sulej, Krystyna Karnewska,** T. Farrell,* and S. Jablonska *IMMCO Diagnostics, Inc., Buffalo, New York 14228; Departments of Microbiology and Dermatology, State University of New York at Buffalo, Buffalo, New York 14214; and Department of Dermatology, Warsaw School of Medicine, Warsaw, Poland; ** Department of Gastroenterology and Pediatrics, Selesian School of Medicine, Warsaw, Poland Clinical Diagnostic Immunology 9:1295-1300, 2002. Celiac.com 12/31/2002 - Background: Immunoglobulin A (IgA) deficiency is 10-15 times more common in patients with Celiac Disease (celiac disease) than in normal subjects. Serological tests have become the preferred methods of detecting both symptomatic and asymptomatic patients with celiac disease. However, commercially available serological methods are limited in that they detect only the IgA isotype of antibodies (with the exception of IgG gliadin assays); hence, IgA deficient celiac disease patients may yield false negative serology. Methods: Fifteen celiac disease and ten non-celiac disease IgA deficient pediatric cases were examined for IgA and IgG antibodies to endomysium, gliadin and tissue transglutaminase. Results: Twenty five specimens with IgA deficiency were examined. Fifteen were celiac disease cases and ten were non-celiac disease cases. All fifteen IgA deficient celiac disease cases were positive for endomysium antibodies of the IgG isotype and for IgG gliadin antibodies. All but one of the IgA deficient celiac disease cases were also positive for IgG tissue transglutaminase antibodies. None of the non-celiac disease IgA deficient cases were positive for any of the antibody markers. All the specimens examined were also negative for IgA specific antibodies to endomysium, gliadin, and tissue transglutaminase. Conclusions: IgG specific antibody tests for endomysium, gliadin and tissue transglutaminase are useful for the identification of IgA deficient celiac disease patients. IgG antibody tests along with tests routinely being used in clinical laboratories can reliably detect all active celiac disease patients. In addition, the levels of these celiac disease-specific IgG antibodies could be used to monitor patient dietary compliance.